하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
SEOUL, Korea – Global aesthetic medical device company HIRONIC Co., Ltd. announced that a lecture featuring its latest device, SYNERJET, was held on November 16 at the 7th Annual Scientific Meeting & International Symposium of the Korean Lifting Society, hosted at COEX Convention Center in Seoul.
The event convened leading domestic and international experts in lifting and skin treatment to share emerging trends and technologies. As the demand rises for non-invasive skin booster solutions that minimize damage while enhancing active ingredient delivery, HIRONIC’s SYNERJET garnered significant attention as a cutting-edge response to this trend.
Dr. Sang-Hoon Lee, Medical Director of YEPPEUMJUYI Clinic, led the lecture, focusing on the key factors that determine treatment outcomes—absorption depth, skin hydration, and spray control. Highlighting the differences between conventional needle-based methods and SYNERJET’s needle-free technology, Dr. Lee presented clinical data underscoring the device’s uniform spray mechanism and efficient ingredient delivery. His insights drew strong interest from attending practitioners.
SYNERJET is HIRONIC’s latest needle-free device that uses microjet technology to deliver skin boosters with minimal surface damage. The system ensures precise control and high stability, making it a versatile solution suitable for various skin conditions. Compared to existing needle-free devices, SYNERJET is highly rated for its technical precision and user safety.
A HIRONIC spokesperson stated, “SYNERJET is designed to offer a delicate yet precise solution, combining safety and convenience. We will continue to strengthen our market competitiveness by collaborating with medical experts and enhancing trust in our technologies.”
